FDA Slams Stem Cell Company For Violations
10:29 EDT 27 Jun 2012 | Pharmalot
Four months ago, a bioethics professor at the University of Minnesota asked the FDA to investigate a stem cell company called Celltex Therapeutics, which has ties to a controversial stem cell company in South Korea called RNL BIO, over concerns about..
Original Article: FDA Slams Stem Cell Company For Violations
More From BioPortfolio on "FDA Slams Stem Cell Company For Violations"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
